ArticleNPJ breast cancer2017
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline
J K Litton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled ittrialcites it